Pro Medicus Ltd
OTC:PMCUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pro Medicus Ltd
OTC:PMCUF
|
AU |
|
M
|
MGIC Investment Corp
BMV:MTG
|
US |
|
Paragon REIT
F:50E
|
SG |
|
L
|
Lithia Motors Inc
SWB:LMO
|
US |
|
DFDS AS
F:29K
|
DK |
|
S
|
SS Lazio SpA
LSE:0MS9
|
IT |
|
H
|
Healthequity Inc
F:2HE
|
US |
|
U
|
Unilever PLC
NYSE:UL
|
UK |
|
A
|
Align Technology Inc
XBER:AFW
|
US |
|
W
|
Walmart Inc
XBER:WMT
|
US |
|
G
|
GT Biopharma Inc
PAR:GTBP
|
US |
|
Societe LDC SA
F:LC41
|
FR |
Wall St Price Targets
PMCUF Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PMCUF is 154.615 USD with a low forecast of 109.52 USD and a high forecast of 193.91 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PMCUF's stock price target?
Price Target
154.615
USD
According to Wall Street analysts, the average 1-year price target for PMCUF is 154.615 USD with a low forecast of 109.52 USD and a high forecast of 193.91 USD.
What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 15%.
What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 13%.
